Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy.
Z Med Phys. 2022 May;32(2):149-158. doi: 10.1016/j.zemedi.2021.03.004. Epub 2021 May 7.
Z Med Phys. 2022.
PMID: 33966944
Free PMC article.
Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation.
Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rübe C.
Niewald M, et al. Among authors: berdel c.
Radiat Oncol. 2011 Oct 21;6:141. doi: 10.1186/1748-717X-6-141.
Radiat Oncol. 2011.
PMID: 22017800
Free PMC article.
Item in Clipboard
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Thurner L, Ziepert M, Berdel C, Schmidt C, Borchmann P, Kaddu-Mulindwa D, Viardot A, Witzens-Harig M, Dierlamm J, Haenel M, Metzner B, Wulf G, Lengfelder E, Keller UB, Frickhofen N, Nickelsen M, Gaska T, Griesinger F, Mahlberg R, Marks R, Shpilberg O, Lindemann HW, Soekler M, Fischer von Weikersthal L, Kiehl M, Roemer E, Bentz M, Krammer-Steiner B, Trappe R, de Nully Brown P, Federico M, Merli F, Engelhard M, Glass B, Schmitz N, Truemper L, Bewarder M, Hartmann F, Murawski N, Stilgenbauer S, Rosenwald A, Altmann B, Schmidberger H, Fleckenstein J, Loeffler M, Poeschel V, Held G.
Thurner L, et al. Among authors: berdel c.
Hemasphere. 2023 Jul 5;7(7):e904. doi: 10.1097/HS9.0000000000000904. eCollection 2023 Jul.
Hemasphere. 2023.
PMID: 37427146
Free PMC article.
Item in Clipboard
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Held G, Thurner L, Poeschel V, Ott G, Schmidt C, Christofyllakis K, Viardot A, Borchmann P, Engel-Riedel W, Frickhofen N, Nickelsen M, Shpilberg O, Witzens-Harig M, Griesinger F, Krammer-Steiner B, Neubauer A, de Nully Brown P, Federico M, Glass B, Schmitz N, Wulf G, Truemper L, Bewarder M, Murawski N, Stilgenbauer S, Rosenwald A, Altmann B, Engelhard M, Schmidberger H, Fleckenstein J, Berdel C, Loeffler M, Ziepert M.
Held G, et al. Among authors: berdel c.
Hemasphere. 2023 Jul 5;7(7):e917. doi: 10.1097/HS9.0000000000000917. eCollection 2023 Jul.
Hemasphere. 2023.
PMID: 37427145
Free PMC article.
Item in Clipboard
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
Pfreundschuh M, Murawski N, Zeynalova S, Ziepert M, Loeffler M, Hänel M, Dierlamm J, Keller U, Dreyling M, Truemper L, Frickhofen N, Hünerlitürkoglu AN, Schmitz N, Pöschel V, Rixecker T, Berdel C, Rübe C, Held G, Zwick C.
Pfreundschuh M, et al. Among authors: berdel c.
Br J Haematol. 2017 Nov;179(3):410-420. doi: 10.1111/bjh.14860. Epub 2017 Oct 8.
Br J Haematol. 2017.
PMID: 28990173
Free article.
Clinical Trial.
Item in Clipboard
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance.
Poeschel V, et al. Among authors: berdel c.
Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9.
Lancet. 2019.
PMID: 31868632
Clinical Trial.
Item in Clipboard
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial.
Kaddu-Mulindwa D, Lesan V, Berdel C, Stilgenbauer S, Bewarder M, Thurner L, Witzens-Harig M, Viardot A, Soekler M, Keller U, Truemper L, Christofyllakis K, Fleser O, Bittenbring JT, Poeschel V, Held G, Jagoda P.
Kaddu-Mulindwa D, et al. Among authors: berdel c.
Leuk Lymphoma. 2022 Feb;63(2):326-334. doi: 10.1080/10428194.2021.1975193. Epub 2021 Oct 20.
Leuk Lymphoma. 2022.
PMID: 34668817
Item in Clipboard
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists.
Oertel M, Berdel C, Held G, Herfarth K, Schmidberger H, Ernst M, Lenz G, Borchmann P, Eich HT.
Oertel M, et al. Among authors: berdel c.
Strahlenther Onkol. 2023 Feb;199(2):115-120. doi: 10.1007/s00066-022-02035-9. Epub 2023 Jan 4.
Strahlenther Onkol. 2023.
PMID: 36598520
Free PMC article.
Review.
Item in Clipboard
Cite
Cite